ACAT2 as a novel therapeutic target to treat fatty liver disease

被引：5
|
作者：
Romeo, Stefano [1 ,2 ,3 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Dept Mol & Clin Med,Inst Med, Bruna Straket 16, S-41345 Gothenburg, Vastra Gotaland, Sweden
[2] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[3] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Clin Nutr Unit, Catanzaro, Italy
来源：
JOURNAL OF INTERNAL MEDICINE | 2022年 / 292卷 / 02期
关键词：
NASH; Fatty liver; Soat2; MAFLD; NAFLD;
D O I：
10.1111/joim.13460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 176
页数：2
相关论文
共 50 条
  • [41] C1INH: A NOVEL THERAPEUTIC TARGET TO TREAT BILIARY ATRESIA AND LIVER FIBROSIS
    Navabi, Nazanin
    Gutta, Sridevi
    Mourya, Reena
    Holmes, Kevin
    Iskenderian, Andrea
    Islam, Rizwana
    Rong, Haojing
    Norton, Angela
    Sypek, Joseph
    Shivakumar, Pranavkumar
    GASTROENTEROLOGY, 2019, 156 (06) : S1507 - S1507
  • [42] Fatty Acid Metabolism Provides a Potential Therapeutic Target To Treat Graft-Versus-Host Disease
    Byersdorfer, Craig A.
    Tkachev, Victor
    Goodell, Stefanie
    Swanson, Jacob
    Ferrara, James L. M.
    BLOOD, 2013, 122 (21)
  • [43] Probing the role of hepatic cholesterol esterification in atherosclerosis promotion via liver-specific depiction of ACAT2
    Brown, Jonathan Mark
    Lemonidis, Kristina M.
    Graham, Mark J.
    Crooke, Rosanne M.
    Rudel, Lawrence L.
    FASEB JOURNAL, 2007, 21 (05): : A109 - A109
  • [44] SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
    Colak, Yasar
    Ozturk, Oguzhan
    Senates, Ebubekir
    Tuncer, Ilyas
    Yorulmaz, Elif
    Adali, Gupse
    Doganay, Levent
    Enc, Feruze Yilmaz
    MEDICAL SCIENCE MONITOR, 2011, 17 (05): : HY5 - HY9
  • [45] Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target
    Colak, Yasar
    Hasan, Badar
    Erkalma, Banu
    Tandon, Kanwarpreet
    Zervos, Xaralambos
    Lo Menzo, Emanuele
    Erim, Tolga
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [46] NOX as a Therapeutic Target in Liver Disease
    Matuz-Mares, Deyamira
    Vazquez-Meza, Hector
    Magdalena Vilchis-Landeros, Maria
    ANTIOXIDANTS, 2022, 11 (10)
  • [47] Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease
    Song, Yongfeng
    Gao, Ling
    EBIOMEDICINE, 2020, 58
  • [48] Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target
    Chen, Hanqing
    LIVER RESEARCH, 2022, 6 (04) : 203 - 213
  • [49] Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
    Lin, Chuan-Hao
    Kohli, Rohit
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
  • [50] ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease
    Shibuya, Yohei
    Chang, Catherine C. Y.
    Chang, Ta-Yuan
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (18) : 2451 - 2467
12345